Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 252

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 252
---
 is in our best interests to make determinations regarding such leadership structure based on
circumstances from time to time. Currently, our Chief Executive Officer serves as the chairman of the board of directors.

Our board of directors believe
that this leadership structure, combined with our corporate governance policies and processes, creates an appropriate balance between
strong and consistent leadership and independent oversight of our business. The chairman chairs the meetings of our board of directors
and stockholders, with input from the independent directors, and as such, our board of directors believes that a person with comprehensive
knowledge of our company is in the best position to serve such role. In making this determination, the board of directors considered,
among other matters, Mr. Ehrlich’s management of our business on a day-to-day basis coupled with his direct involvement in our
business operations, and believed that Mr. Ehrlich is highly qualified to act as both chairman and Chief Executive Officer due to his
experience, knowledge and history with both Legacy CERo and PBAX.

In addition, each of our
other directors is “independent” under Nasdaq standards. Our independent vice chairman presides over regularly-held executive
sessions of independent directors, without management present, and all of our independent directors are active in the oversight of our
company. In addition, our board of directors and each committee of board of directors has complete and open access to any member of management
and the authority to retain independent legal, financial and other advisors as they deem appropriate.

Our board of directors believe
its administration of its risk oversight function has not affected its leadership structure. Risk is inherent with every business, and
how well a business manages risk can ultimately determine its success. Our board of directors is actively involved in oversight of risks
that could affect us. This oversight is conducted primarily by our full board of directors, which has responsibility for general oversight
of risks, and the Audit Committee, which has responsibility for reviewing the adequacy of our risk management activities with management
and our independent registered public accounting firm.

At each of its meetings,
the board of directors receives business updates from various members of management. These updates may identify matters that have emerged
within that member of management’s scope of responsibility that involve operational, financial, legal or regulatory risks and,
in these cases, the board of directors provides guidance to management. Our board of directors believes that full and open communication
between management and the board of directors is essential for effective risk management and oversight.

<div align='center'>146</div